Immune response to melanoma extracts in three melanoma-prone families

Arthur A. Vandenbark; Mark H. Greene; Denis R. Burger; R. Mark Vetto; Ronald R. Reimer

doi:10.1093/jnci/63.5.1147

Immune response to melanoma extracts in three melanoma-prone families

Arthur A. Vandenbark
, Mark H. Greene
, Denis R. Burger
, R. Mark Vetto
, Ronald R. Reimer

Neurology

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

Immune reactivity to melanoma extracts was measured by the leukocyte adherence Inhibition (LAI) test In 40 members of 3 melanoma-prone families. The melanoma patients had a wide range of responsiveness to the extract, the highest responder being a 10-year survivor. As a group, family members (Including spouses) without disease had significantly elevated LAI responses compared to those of unrelated controls (P<0.01). Within the families, members with close exposure to melanoma patients for 10 years or more had a significantly higher response to melanoma antigen than did members with 0-5 years of close exposure (P<0.05). Responses of spouses and members at high risk of developing melanoma (B-K mole syndrome) also correlated with length of exposure to patients, which suggests that the elevated LAI response was not genetically determined. The high frequency of positive responses to melanoma antigens In these families, particularly In spouses, suggests the presence of transmissible melanoma-associated material capable of Immunizing persons In contact with melanoma patients.

Original language	English (US)
Pages (from-to)	1147-1151
Number of pages	5
Journal	Journal of the National Cancer Institute
Volume	63
Issue number	5
DOIs	https://doi.org/10.1093/jnci/63.5.1147
State	Published - Nov 1979

Funding

1 Received October 27, 1978; accepted April 10, 1979. 2 Supported in part by Public Health Service contract NOICB53954 from the Division of Cancer Biology and Diagnosis, National Cancer Institute, and by Veterans Administration Project No. 648-9012. 3 Surgical Research Laboratory, Veterans Administration Medical Center, 3710 S.W. U.S. Veterans Hospital Rd., Portland, Oreg. 97207. 4 Department of Microbiology and Immunology, University of Oregon Health Sciences Center, Portland, Oreg. 97201. S Address reprint requests to Dr. Vandenbark at his first address. 6 Environmental Epidemiology Branch, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health, Public Health Service, U.S. Department of Health, Education, and Welfare, Bethesda, Md. 20205. 7 Department of Surgery, University of Oregon Health Sciences Center. 8 Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, Ohio 44106.

Funders	Funder number
Veterans Administration	648-9012
National Institute of Health-National Cancer Institute
U.S. Public Health Service	NOICB53954

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1093/jnci/63.5.1147

Cite this

@article{7f2b350e951a402e9e21a926d3ff9c37,

title = "Immune response to melanoma extracts in three melanoma-prone families",

abstract = "Immune reactivity to melanoma extracts was measured by the leukocyte adherence Inhibition (LAI) test In 40 members of 3 melanoma-prone families. The melanoma patients had a wide range of responsiveness to the extract, the highest responder being a 10-year survivor. As a group, family members (Including spouses) without disease had significantly elevated LAI responses compared to those of unrelated controls (P<0.01). Within the families, members with close exposure to melanoma patients for 10 years or more had a significantly higher response to melanoma antigen than did members with 0-5 years of close exposure (P<0.05). Responses of spouses and members at high risk of developing melanoma (B-K mole syndrome) also correlated with length of exposure to patients, which suggests that the elevated LAI response was not genetically determined. The high frequency of positive responses to melanoma antigens In these families, particularly In spouses, suggests the presence of transmissible melanoma-associated material capable of Immunizing persons In contact with melanoma patients.",

author = "Vandenbark, \{Arthur A.\} and Greene, \{Mark H.\} and Burger, \{Denis R.\} and \{Mark Vetto\}, R. and Reimer, \{Ronald R.\}",

note = "Funding Information: 1 Received October 27, 1978; accepted April 10, 1979. 2 Supported in part by Public Health Service contract NOICB53954 from the Division of Cancer Biology and Diagnosis, National Cancer Institute, and by Veterans Administration Project No. 648-9012. 3 Surgical Research Laboratory, Veterans Administration Medical Center, 3710 S.W. U.S. Veterans Hospital Rd., Portland, Oreg. 97207. 4 Department of Microbiology and Immunology, University of Oregon Health Sciences Center, Portland, Oreg. 97201. S Address reprint requests to Dr. Vandenbark at his first address. 6 Environmental Epidemiology Branch, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health, Public Health Service, U.S. Department of Health, Education, and Welfare, Bethesda, Md. 20205. 7 Department of Surgery, University of Oregon Health Sciences Center. 8 Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, Ohio 44106.",

year = "1979",

month = nov,

doi = "10.1093/jnci/63.5.1147",

language = "English (US)",

volume = "63",

pages = "1147--1151",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - Immune response to melanoma extracts in three melanoma-prone families

AU - Vandenbark, Arthur A.

AU - Greene, Mark H.

AU - Burger, Denis R.

AU - Mark Vetto, R.

AU - Reimer, Ronald R.

N1 - Funding Information: 1 Received October 27, 1978; accepted April 10, 1979. 2 Supported in part by Public Health Service contract NOICB53954 from the Division of Cancer Biology and Diagnosis, National Cancer Institute, and by Veterans Administration Project No. 648-9012. 3 Surgical Research Laboratory, Veterans Administration Medical Center, 3710 S.W. U.S. Veterans Hospital Rd., Portland, Oreg. 97207. 4 Department of Microbiology and Immunology, University of Oregon Health Sciences Center, Portland, Oreg. 97201. S Address reprint requests to Dr. Vandenbark at his first address. 6 Environmental Epidemiology Branch, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health, Public Health Service, U.S. Department of Health, Education, and Welfare, Bethesda, Md. 20205. 7 Department of Surgery, University of Oregon Health Sciences Center. 8 Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, Ohio 44106.

PY - 1979/11

Y1 - 1979/11

N2 - Immune reactivity to melanoma extracts was measured by the leukocyte adherence Inhibition (LAI) test In 40 members of 3 melanoma-prone families. The melanoma patients had a wide range of responsiveness to the extract, the highest responder being a 10-year survivor. As a group, family members (Including spouses) without disease had significantly elevated LAI responses compared to those of unrelated controls (P<0.01). Within the families, members with close exposure to melanoma patients for 10 years or more had a significantly higher response to melanoma antigen than did members with 0-5 years of close exposure (P<0.05). Responses of spouses and members at high risk of developing melanoma (B-K mole syndrome) also correlated with length of exposure to patients, which suggests that the elevated LAI response was not genetically determined. The high frequency of positive responses to melanoma antigens In these families, particularly In spouses, suggests the presence of transmissible melanoma-associated material capable of Immunizing persons In contact with melanoma patients.

AB - Immune reactivity to melanoma extracts was measured by the leukocyte adherence Inhibition (LAI) test In 40 members of 3 melanoma-prone families. The melanoma patients had a wide range of responsiveness to the extract, the highest responder being a 10-year survivor. As a group, family members (Including spouses) without disease had significantly elevated LAI responses compared to those of unrelated controls (P<0.01). Within the families, members with close exposure to melanoma patients for 10 years or more had a significantly higher response to melanoma antigen than did members with 0-5 years of close exposure (P<0.05). Responses of spouses and members at high risk of developing melanoma (B-K mole syndrome) also correlated with length of exposure to patients, which suggests that the elevated LAI response was not genetically determined. The high frequency of positive responses to melanoma antigens In these families, particularly In spouses, suggests the presence of transmissible melanoma-associated material capable of Immunizing persons In contact with melanoma patients.

UR - https://www.scopus.com/pages/publications/0018579347

UR - https://www.scopus.com/pages/publications/0018579347#tab=citedBy

U2 - 10.1093/jnci/63.5.1147

DO - 10.1093/jnci/63.5.1147

M3 - Article

C2 - 291746

AN - SCOPUS:0018579347

SN - 0027-8874

VL - 63

SP - 1147

EP - 1151

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

IS - 5

ER -

Immune response to melanoma extracts in three melanoma-prone families

Abstract

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this